You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Progression

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)

Not yet recruiting
  • Biliary Tract Cancer
  • +3 more
  • (no location specified)
Aug 16, 2022

Advanced Melanoma

Enrolling by invitation
  • Melanoma
  • observational
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma Trial (DCVAC/OvCa, DCVAC/OvCa )

Withdrawn
  • Ovarian Cancer
  • +2 more
  • DCVAC/OvCa
  • DCVAC/OvCa placebo
  • (no location specified)
Dec 6, 2021

Breast Cancer Trial in Athens

Recruiting
  • Breast Cancer
    • Athens, Greece
      Hellenic Oncology Cooperative Group
    May 13, 2022

    Breast Cancer Trial in Detroit (biological, drug, other)

    Terminated
    Has Results
    • Breast Cancer
    • HER2Bi-armed activated T cells
    • +2 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Nov 29, 2022

    Nasopharyngeal Carcinoma Trial in San Francisco, Singapore (Nivolumab, Cisplatin, Radiation Therapy)

    Recruiting
    • Nasopharyngeal Carcinoma
    • San Francisco, California
    • +1 more
    Feb 7, 2022

    Scoliosis Trial in Rochester (AVBT using Dynesys System Components, Spine fusion)

    Recruiting
    • Scoliosis
    • AVBT using Dynesys System Components
    • Spine fusion
    • Rochester, Minnesota
      Mayo Clinic
    Jun 23, 2022

    NSCLC Trial in London (MPDL3280A, Vemurafenib, Alectinib)

    Recruiting
    • Non-small Cell Lung Cancer
    • London, United Kingdom
      Univeristy College London Hospital
    Feb 22, 2022

    Efficacy After Anti-androgen Therapy for CRPC

    Active, not recruiting
    • Castration Resistant Prostate Cancer (CRPC)
      • (no location specified)
      Jan 5, 2021

      Breast Cancer, Breast Adenocarcinoma, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Bronx (Rebastinib,

      Terminated
      • Breast Cancer
      • +4 more
      • Bronx, New York
        Montefiore Medical Center
      Mar 23, 2022

      Ovarian Cancer Trial in Italy (Pembrolizumab, Paclitaxel, Carboplatin)

      Recruiting
      • Ovarian Cancer
      • Acquaviva delle Fonti, Italy
      • +12 more
      Mar 2, 2021

      Uterine Carcinosarcoma, Advanced Uterine Carcinosarcoma Trial in United States (Pembrolizumab, Lenvatinib)

      Recruiting
      • Uterine Carcinosarcoma
      • Advanced Uterine Carcinosarcoma
      • Basking Ridge, New Jersey
      • +6 more
      Apr 27, 2022

      Tumors, Rectal Trial (Dostarlimab)

      Not yet recruiting
      • Neoplasms, Rectal
      • Dostarlimab
      • (no location specified)
      Feb 2, 2023

      24-hour Urinary Electrolyte Excretion in Chronic Kidney Disease

      Completed
      • Chronic Kidney Diseases
      • Electrolyte Imbalance
        • (no location specified)
        Sep 19, 2022

        Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece

        Completed
        • Metastatic Colorectal Cancer
        • Heraklion, Crete, Greece
        • +7 more
        Mar 4, 2022

        Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

        Active, not recruiting
        • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
        • +2 more
        • Columbus, Ohio
        • +2 more
        Aug 10, 2022

        Hepatocellular Carcinoma Trial (SBRT + atezolizumab and bevacizumab)

        Not yet recruiting
        • Hepatocellular Carcinoma
        • SBRT + atezolizumab and bevacizumab
        • (no location specified)
        Aug 3, 2022

        Locally Advanced Basal Cell Carcinoma Trial in Brescia (Sonidegib)

        Recruiting
        • Locally Advanced Basal Cell Carcinoma
        • Brescia, Italy
          Asst Degli Spedali Civili Di Brescia
        Aug 3, 2022

        Metastatic Breast Cancer Trial in Chuo-ku, Nihonbashi, Koami-cho (Paclitaxel, Bevacizumab, Letrozole)

        Completed
        • Metastatic Breast Cancer
        • Chuo-ku, Nihonbashi, Koami-cho, Tokyo, Japan
          Japan Breast Cancer Research Group
        Aug 2, 2022

        Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

        Recruiting
        • Endometrial Serous Adenocarcinoma
        • +2 more
        • Biopsy
        • +3 more
        • Phoenix, Arizona
        • +3 more
        Feb 2, 2023

        Prediction of Chronic Allograft Nephropathy

        Completed
        • Kidney Transplantation
        • +2 more
        • mRNAs encoding genes
        • Paris, France
          Necker Hospital
        Apr 13, 2021

        Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Seattle (Fecal Microbiota Transplantation Capsule, Placebo)

        Not yet recruiting
        • Acute Graft Versus Host Disease
        • Hematopoietic and Lymphoid System Neoplasm
        • Fecal Microbiota Transplantation Capsule
        • Placebo
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Sep 6, 2023

        Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Santa Monica (Trabectedin, Ipilimumab, Nivolumab)

        Recruiting
        • Advanced Soft Tissue Sarcoma
        • Metastatic Soft Tissue Sarcoma
        • Santa Monica, California
          Sarcoma Oncology Research Center
        May 4, 2022

        Prostate Cancer Recurrent Trial in Lexington (Hydroxychloroquine Sulfate 200Mg Tab)

        Recruiting
        • Prostate Cancer Recurrent
        • Hydroxychloroquine Sulfate 200Mg Tab
        • Lexington, Kentucky
          Markey Cancer Center - University of Kentucky
        Jul 6, 2021

        Cleveland Heart and Metabolic Prevention Study

        Active, not recruiting
        • Heart Failure Risk Factors in Healthy Individuals
          • Cleveland, Ohio
            Cleveland Clinic
          Sep 28, 2022